Redox regulation of cardiomyocyte cell cycling via an ERK1/2 and c-Myc-dependent activation of cyclin D2 transcription

Journal of Molecular and Cellular Cardiology

Volumn 79, Issue , 2015, Pages 54-68

  Murray, Thomas V A ^a   Smyrnias, Ioannis ^a   Schnelle, Moritz ^a   Mistry, Rajesh K ^a   Zhang, Min ^a   Beretta, Matteo ^a   Martin, Daniel ^a   Anilkumar, Narayana ^a   de Silva, Shana M ^a   Shah, Ajay M ^a   Brewer, Alison C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

C Myc; Cardiomyocyte proliferation; Cyclin D2; ERK1 2; Nox4; Redox signalling

Indexed keywords

BROXURIDINE; CYCLIN D2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTOME; MITOGEN ACTIVATED PROTEIN KINASE; NOX4 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CARDIOMEGALY; CELL COUNT; CELL CYCLE REGULATION; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; PERINATAL PERIOD; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CYCLE; CONSERVED SEQUENCE; CYTOLOGY; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BINDING SITES; CARDIOMEGALY; CELL CYCLE; CELL PROLIFERATION; CONSERVED SEQUENCE; CYCLIN D2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYOCARDIUM; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATION-REDUCTION; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RATS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84910672672     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.10.017     Document Type: Article

References (64)

1. Bicknell K.A., Coxon C.H., Brooks G. Can the cardiomyocyte cell cycle be reprogrammed?. J Mol Cell Cardiol 2007, 42:706-721.
2. Drenckhahn J.D., Schwarz Q.P., Gray S., Laskowski A., Kiriazis H., Ming Z., et al. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev Cell 2008, 15:521-533.
3. Porrello E.R., Mahmoud A.I., Simpson E., Hill J.A., Richardson J.A., Olson E.N., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
4. Ahuja P., Sdek P., MacLellan W.R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007, 87:521-544.
5. Chiu J., Dawes I.W. Redox control of cell proliferation. Trends Cell Biol 2012, 22:592-601.
6. Jones N.C., Fedorov Y.V., Rosenthal R.S., Olwin B.B. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 2001, 186:104-115.
7. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
8. Yamakawa T., Tanaka S., Kamei J., Kadonosono K., Okuda K. Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signal-regulated kinases 1/2. J Atheroscler Thromb 2003, 10:37-42.
9. Chiarugi P. PTPs versus PTKs: the redox side of the coin. Free Radic Res 2005, 39:353-364.
10. Buggisch M., Ateghang B., Ruhe C., Strobel C., Lange S., Wartenberg M., et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 2007, 120:885-894.
11. Sauer H., Neukirchen W., Rahimi G., Grunheck F., Hescheler J., Wartenberg M. Involvement of reactive oxygen species in cardiotrophin-1-induced proliferation of cardiomyocytes differentiated from murine embryonic stem cells. Exp Cell Res 2004, 294:313-324.
12. Przybyt E., Krenning G., Brinker M.G., Harmsen M.C. Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. J Transl Med 2013, 11:39.
13. Santos C.X., Anilkumar N., Zhang M., Brewer A.C., Shah A.M. Redox signaling in cardiac myocytes. Free Radic Biol Med 2011, 50:777-793.
14. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
15. Chan E.C., Jiang F., Peshavariya H.M., Dusting G.J. Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol Ther 2009, 122:97-108.
16. Zhang M., Brewer A.C., Schroder K., Santos C.X., Grieve D.J., Wang M., et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 2010, 107:18121-18126.
17. Ago T., Kuroda J., Pain J., Fu C., Li H., Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 2010, 106:1253-1264.
18. Heymes C., Bendall J.K., Ratajczak P., Cave A.C., Samuel J.L., Hasenfuss G., et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003, 41:2164-2171.
19. Takac I., Schroder K., Zhang L., Lardy B., Anilkumar N., Lambeth J.D., et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 2011, 286:13304-13313.
20. Serrander L., Cartier L., Bedard K., Banfi B., Lardy B., Plastre O., et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007, 406:105-114.
21. Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 2002, 90:1044-1054.
22. Kozar K., Ciemerych M.A., Rebel V.I., Shigematsu H., Zagozdzon A., Sicinska E., et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004, 118:477-491.
23. Soonpaa M.H., Koh G.Y., Pajak L., Jing S., Wang H., Franklin M.T., et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997, 99:2644-2654.
24. Yamak A., Temsah R., Maharsy W., Caron S., Paradis P., Aries A., et al. Cyclin D2 rescues size and function of GATA4 haplo-insufficient hearts. Am J Physiol Heart Circ Physiol 2012, 303:H1057-H1066.
25. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991, 19:2499.
26. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
27. Murray T.V., Smyrnias I., Shah A.M., Brewer A.C. NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun and the cis-regulation of GATA-4 transcription. J Biol Chem 2013, 288(22):15745-15759.
28. Antoons G., Mubagwa K., Nevelsteen I., Sipido K.R. Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol 2002, 543:889-898.
29. Brewer A.C., Murray T.V., Arno M., Zhang M., Anilkumar N.P., Mann G.E., et al. Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radic Biol Med 2011, 51:205-215.
30. Zhong W., Mao S., Tobis S., Angelis E., Jordan M.C., Roos K.P., et al. Hypertrophic growth in cardiac myocytes is mediated by myc through a cyclin D2-dependent pathway. EMBO J 2006, 25:3869-3879.
31. Busk P.K., Hinrichsen R., Bartkova J., Hansen A.H., Christoffersen T.E., Bartek J., et al. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res 2005, 304:149-161.
32. Pasumarthi K.B., Nakajima H., Nakajima H.O., Soonpaa M.H., Field L.J. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005, 96:110-118.
33. Borlado L.R., Mendez J. CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 2008, 29:237-243.
34. Anilkumar N., Weber R., Zhang M., Brewer A., Shah A.M. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol 2008, 28:1347-1354.
35. Mebratu Y., Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer?. Cell Cycle 2009, 8:1168-1175.
36. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., et al. Direct induction of cyclin D2 by myc contributes to cell cycle progression and sequestration of p27. EMBO J 1999, 18:5321-5333.
37. Bouchard C., Dittrich O., Kiermaier A., Dohmann K., Menkel A., Eilers M., et al. Regulation of cyclin D2 gene expression by the myc/max/mad network: myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 2001, 15:2042-2047.
38. Alvarez E., Northwood I.C., Gonzalez F.A., Latour D.A., Seth A., Abate C., et al. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem 1991, 266:15277-15285.
39. Sears R., Nuckolls F., Haura E., Taya Y., Tamai K., Nevins J.R. Multiple Ras-dependent phosphorylation pathways regulate myc protein stability. Genes Dev 2000, 14:2501-2514.
40. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002, 1:226-231.
41. Houtgraaf J.H., Versmissen J., van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 2006, 7:165-172.
42. Tamamori-Adachi M., Goto I., Yamada K., Kitajima S. Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation. Cell Cycle 2008, 7:3768-3774.
43. Tamamori-Adachi M., Ito H., Nobori K., Hayashida K., Kawauchi J., Adachi S., et al. Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy. Biochem Biophys Res Commun 2002, 296:274-280.
44. Martinez Munoz C., Post J.A., Verkleij A.J., Verrips C.T., Boonstra J. The effect of hydrogen peroxide on the cyclin D expression in fibroblasts. Cell Mol Life Sci 2001, 58:990-996.
45. Sturrock A., Cahill B., Norman K., Huecksteadt T.P., Hill K., Sanders K., et al. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006, 290:L661-L673.
46. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005, 280:39616-39626.
47. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012, 66:105-143.
48. Martino A., Holmes J.H.T., Lord J.D., Moon J.J., Nelson B.H. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol 2001, 166:1723-1729.
49. Merchant J.L., Du M., Todisco A. Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 1999, 254:454-461.
50. Pircher T.J., Petersen H., Gustafsson J.A., Haldosen L.A. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol Endocrinol 1999, 13:555-565.
51. Yamaura M., Mitsushita J., Furuta S., Kiniwa Y., Ashida A., Goto Y., et al. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 2009, 69:2647-2654.
52. Sturrock A., Huecksteadt T.P., Norman K., Sanders K., Murphy T.M., Chitano P., et al. Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1543-L1555.
53. Crosas-Molist E., Bertran E., Sancho P., Lopez-Luque J., Fernando J., Sanchez A., et al. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression. Free Radic Biol Med 2014, 69:338-347.
54. Sherr C.J., Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004, 18:2699-2711.
55. Reiss K., Cheng W., Ferber A., Kajstura J., Li P., Li B., et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A 1996, 93:8630-8635.
56. Meng D., Lv D.D., Fang J. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc Res 2008, 80:299-308.
57. Qiao M., Shapiro P., Kumar R., Passaniti A. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J Biol Chem 2004, 279:42709-42718.
58. Nakamura T., Colbert M., Krenz M., Molkentin J.D., Hahn H.S., Dorn G.W., et al. Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J Clin Invest 2007, 117:2123-2132.
59. Poolman R.A., Li J.M., Durand B., Brooks G. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res 1999, 85:117-127.
60. Lloyd A.C. The regulation of cell size. Cell 2013, 154:1194-1205.
61. Hassink R.J., Pasumarthi K.B., Nakajima H., Rubart M., Soonpaa M.H., de la Riviere A.B., et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res 2008, 78:18-25.
62. Nakajima H., Nakajima H.O., Dembowsky K., Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium. Circ Res 2006, 98:141-148.
63. Balasubramanyam K., Swaminathan V., Ranganathan A., Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 2003, 278:19134-19140.
64. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006, 6:38-51.